The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases. [electronic resource]
Producer: 20170814Description: 1069-1077 p. digitalISSN:- 1879-355X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Brain Neoplasms -- genetics
- Female
- Genes, ras
- Humans
- Immunotherapy
- Linear Models
- Male
- Melanoma -- genetics
- Middle Aged
- Molecular Targeted Therapy
- Mutation
- Prognosis
- Proportional Hazards Models
- Proto-Oncogene Proteins B-raf -- genetics
- Proto-Oncogene Proteins c-kit -- genetics
- Retrospective Studies
- Statistics, Nonparametric
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.